Meeting
2019 ASCO Annual Meeting
Multi-institutional analysis of outcomes in patients with dedifferentiated chondrosarcoma (DDCS).
Authors
Nam Bui
Stanford Cancer Institute, Palo Alto, CA
Nam Bui , Hilary Dietz , Angela C. Hirbe , Kristen N. Ganjoo , Brian Andrew Van Tine , Vicki Leigh Keedy , Elizabeth J. Davis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Bone Tumors
Citation
J Clin Oncol 37, 2019 (suppl; abstr 11028)
DOI
10.1200/JCO.2019.37.15_suppl.11028
Abstract #
11028
Poster Bd #
351
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Gemcitabine-docetaxel in patients with relapsed high-grade osteosarcoma after first-line treatment with high-dose ifosfamide: A retrospective multicenter study.
First Author: Maria Grazia Pionelli
Poster
2023 ASCO Genitourinary Cancers Symposium
A prospective phase II trial of pembrolizumab plus lenvatinib in advanced adrenal cortical carcinoma after failure of platinum- and mitotane-based chemotherapy (ACCOMPLISH).
First Author: Inkeun Park
Poster
2021 ASCO Annual Meeting
A randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib (2ND-STEP, JCOG1802).
First Author: Makoto Endo
Poster
2021 ASCO Annual Meeting
Real-world treatment patterns and clinical outcomes among patients with metastatic urothelial carcinoma.
First Author: Daniel M. Geynisman